MENU
CDTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Cidara Therapeutics (CDTX) Ownership - Who owns Cidara Therapeutics?
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
6310 Nancy Ridge Drive
Phone
+1 858 752-6170
Employees
73
Web
https://www.cidara.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
251.1M
P/E Ratio
N/A
Total Cash
168.15M
Projected Growth
N/A
Total Debt
2.67M
Revenue
302K
Risk (Beta)
1.12
Dividend Yield
N/A
Total Cash/Share
12.96
Total Debt/Equity
N/A
Revenue/Share
0.03 USD as % of share price
Fundamentals
CDTX
Capitalization
251M
P/E Ratio
N/A
Risk (Beta)
1.12
Dividend Yield
N/A
Total Cash
168M
Total Cash/Share
12.96
Total Debt
2.67M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.03%
Revenue
302K
ROE
N/A
Book Value
142M
P/B Ratio
1.77
Cash Flow
N/A
Earnings
-26.13
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1K
Current Ratio
3.87
Current Revenue Per Employee
4136.99
Dividends Per Share - Security
N/A
EBITDA
-192.6M
Float
N/A
Float - Current
N/A
Gross Income Margin
81.53
Revenue To Assets
-149.71
Shares Held By Institutions
189M
Shares Outstanding - Current
13M
Total Liabilities
50M
Total Volume MTD
N/A
Value
-1
Gain YTD
-27.976
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of drugs for fungal infection
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
6310 Nancy Ridge Drive
Phone
+1 858 752-6170
Employees
73
Web
https://www.cidara.com